RXI PHARMACEUTICALS CORP NEW's ticker is RXIIW and the CUSIP is 74979C121. A total of 4 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 222,173 | $715,000 | 0.53% |
| CVI Holdings, LLC | 221,686 | $100,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 393,044 | $176,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 3,000 | $1,000 | 0.00% |